« Page: 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44 of 44. »
	Product	Alternate Name	Type	Strength	Quantity	Price (USD)	Buy Now
	Seroquel	quetiapine	Brand	300mg	120TAB	$584.00
	Sinemet	levodopa/carbidopa	Brand	100mg/25mg	100TAB	$70.00
	Sinemet CR	levodopa/carbidopa er	Brand	200mg/50mg	100TAB	$122.00
	Sinequan	doxepin	Generic	10mg	100CAP	$50.00
	Sinequan	doxepin	Generic	25mg	100CAP	$50.00
	Sinequan	doxepin	Generic	50mg	100CAP	$52.00
	Sinequan	doxepin	Generic	75mg	100CAP	$57.00
	Sinex Ultra Fine	Nasal Spray	Brand	15ml	1EA	$32.00
	Singulair	monteleukast	Generic	10mg	100TAB	$100.00
	Singulair	monteleukast	Brand	10mg	30TAB	$120.00
	Singulair	monteleukast	Brand	10mg	60TAB	$190.00
	Singulair	monteleukast	Brand	10mg	90TAB	$267.00
	Singulair	monteleukast	Brand	5mg	30TAB	$120.00
	Singulair	monteleukast	Brand	5mg	60TAB	$190.00
	Singulair	monteleukast	Brand	5mg	90TAB	$267.00
	Soriatane	acitretin	Brand	10mg	30CAP	$80.00
	Soriatane	acitretin	Brand	10mg	60CAP	$107.00
	Soriatane	acitretin	Brand	10mg	90CAP	$140.00
	Soriatane	acitretin	Brand	25mg	30CAP	$112.00
	Soriatane	acitretin	Brand	25mg	60CAP	$177.00
	Soriatane	acitretin	Brand	25mg	90CAP	$242.00
	Soriatane	acitretin	Brand	25mg	180CAP	$414.00
	Spiriva HandiHaler	tiotropium bromide inhala...	Brand	18mcg	30CAP	$122.00
	Spiriva HandiHaler	tiotropium bromide inhala...	Brand	18mcg	60CAP	$194.00
« Page: 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44 of 44. »

Offsite Spiriva HandiHaler Blogs

• 2010-03-31 17:34:00
  by 247-Pharmacy.com Blog

  For a time, there was no cure for respiratory problems. Historically people had to simply live with these conditions—today many people live well without having their asthma control them. Thanks to the many devices available to them to help them they can breath easy as they now have the ability to bu ...

• 2010-03-21 07:12:00
  by Allergy Relief Spot

  Press Release 10 March, 2010 The Summary of Product Characteristics (SmPC) for SPIRIVA® HandiHaler® (tiotropium bromide inhalation powder) has been updated to include data from the 4-year placebo controlled UPLIFT® trial, Boehringer Ingelheim and Pfizer announce today. Read more on PharmiWeb

• 2010-02-06 01:37:00
  by Healthyhomeblog

  Sources: buy cheap Lioresal For those of you who take respiratory medications and take them regularly think about how you take them. Do you know if you are doing it right? Being a respiratory therapist I've realized that some people still do not know how to take their medications. I have had to rete ...

• 2010-01-25 01:03:00
  by FDA NEWS

  Recalls and Safety Alerts: Energy Levels in External Biphasic Defibrillators FDA is looking into the safety and effectiveness of biphasic defibrillators used for cardioversion and defibrillation in order to understand the conditions that affect their performance. Over the past three years, FDA has r ...

• 2010-01-20 04:45:00
  by copd prognosis

  Earlier in 2008 various studies thought that intake of Spiriva might cause unwanted effects for heart disease patients.But latest announcements say that it is not true.With this recent announcement, COPD patients felt relieved Spiriva Handihaler is a capsule with inhaler which needs to be taken on a ...

• 2010-01-18 04:42:00
  by

  Spiriva (tiotropium bromide) is an inhaled medication used to prevent exacerbations (”attacks”) caused by COPD, or chronic obstructive pulmonary disease. It’s taken once per day. There were concerns a while ago about a possible connection between using Spiriva and experiencing a higher risk of strok ...

• 2010-01-16 09:32:00
  by SALUTE DOMANI ∞ IL PORTALE DEL BENESSERE

  The U.S. Food and Drug Administration today announced that data from a recent review of the Spiriva HandiHaler, a long-acting respiratory treatment for chronic obstructive pulmonary disease (COPD) , do not support an increased risk of stroke, heart attack, or death in patients using the medicine. CO ...

• 2010-01-15 16:30:00
  by Drug Injury Watch

  This COPD Medication Had Previously Been Possibly Linked To Stroke, Heart Attack, And Death (Posted by Tom Lamb at DrugInjuryWatch.com ) On January 14, 2010 the FDA issued a news release, "FDA Updates Earlier Guidance on Respiratory Treatment Spiriva HandiHaler -- Current data do not support increas ...

• 2010-01-15 11:43:00
  by cdistaffing.com Blog

  The Food and Drug Administration wrapped up a safety review of the lung drug Spiriva HandiHaler, saying the product wasn’t associated with an increased risk of stroke or other cardiovascular problems. Spiriva is approved to treat chronic obstructive pulmonary disease, which includes chronic bronchit ...

• 2010-01-15 11:36:00
  by PharmaLeader - Pharma News

  From Associated Press (January 14, 2010) WASHINGTON--Federal health regulators said Thursday that recent data do not show a connection between a popular inhaler and previously reported risks of stroke, heart attack and death. The Spiriva HandiHaler... ... (Read whole news on source site)

• 2010-01-15 10:01:00
  by BioPharma Today

  Notes From J.P. Morgan: Daschle Disses DTC - FDA Clears Spiriva HandiHaler Of Increased Cardiovascular Risk - Nothing Anemic About Ferahame: The Med Helps Amag Exceeds Street Expectations - Pharma Companies Respond To Haiti Crisis With Medicine And Cash Donations

• 2010-01-15 03:51:00
  by Current R&D of Pharmaceutical

  The U.S. Food and Drug Administration today announced that data from a recent review of the Spiriva, Tiotropium HandiHaler, a long-acting respiratory treatment for chronic obstructive pulmonary disease (COPD), do not support an increased risk of stroke, heart attack, or death in patients using the m ...

• 2010-01-14 23:48:00
  by Y! Health News Search RSS Feed

  HealthDay - THURSDAY, Jan. 14 (HealthDay News) -- The U.S. Food and Drug Administration on Thursday said it found no good evidence that the Spiriva HandiHaler boosts heart risks in patients who use it to help control chronic obstructive pulmonary disease (COPD).